NUCLEIC ACID AND CORRESPONDING PROTEIN ENTITLED 251P5G2 USEFUL IN TREATMENT AND DETECTION OF CANCER

Details for Australian Patent Application No. 2003243151 (hide)

Owner AGENSYS, INC.

Inventors CHALLITA-EID, Pia, M.; JAKOBOVITS, Aya; FARIS, Mary; GE, Wangmao; RAITANO, Arthur, B.

Pub. Number AU-A-2003243151

PCT Number PCT/US03/12354

PCT Pub. Number WO2004/016733

Priority 60/404,306 16.08.02 US; 60/423,290 01.11.02 US

Filing date 17 April 2003

Wipo publication date 3 March 2004

Event Publications

11 September 2003 Complete Application Filed

  Priority application(s): 60/404,306 16.08.02 US; 60/423,290 01.11.02 US

22 April 2004 Application Open to Public Inspection

  Published as AU-A-2003243151

5 May 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003243152-Methods for treating an autoimmune disease using a soluble CTLA4 molecule and a DMARD or NSAID

2003243150-RESORPTION-CONTROLLABLE MEDICAL IMPLANTS